
ポジション概要:
Principal Data Engineer – APJ Data Warehouse は、APJにおけるエンタープライズデータ基盤の設計・構築・高度化を技術面からリードするポジションです。
Snowflakeを中核とした、スケーラブルかつ標準化されたAPJ Data Warehouse(DWH) を構築し、各市場やシステムに分散しているCommercial Dataを、信頼性が高く再利用可能なデータプロダクトとして統合します。
主な対象データドメインは以下です。
· 顧客マスターデータ
o アルトマーク等の顧客データ
· 営業アライメントデータ
o 営業組織、テリトリー、担当者・顧客アサインメント
· 実消化 / JD Salesデータ
· 市場売上データ
· CRM活動データ
o 顧客タッチポイント、CRM営業活動、Digital Engagement Dataなど
これらのデータを統合することで、Business Intelligence、Commercial Analytics、Advanced Analytics、AI が共通利用できるAPJ Data Foundationを構築します。
本ポジションはArchitectureだけを担当する役割ではなく、Snowflake、dbt、Fivetranを自らHands-onで活用できるPrincipal Engineer として活躍いただきます
以下の主要Commercial Data Domainの統合・モデリングをリードします。
Customer Master Data
Sales Alignment
Market Sales Data
CRM Activity Data
Technical Skills
Snowflake
日本語
英語
05-11月-2026
30-1月-2027
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy